Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

H Zhang, X Yue, Z Chen, C Liu, W Wu, N Zhang, Z Liu… - Molecular Cancer, 2023 - Springer
Despite centuries since the discovery and study of cancer, cancer is still a lethal and
intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much …

Glioblastoma heterogeneity at single cell resolution

D Eisenbarth, YA Wang - Oncogene, 2023 - nature.com
Glioblastoma (GBM) is one of the deadliest types of cancer and highly refractory to
chemoradiation and immunotherapy. One of the main reasons for this resistance to therapy …

State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis

M Sollini, M Kirienko, F Gelardi, F Fiz, N Gozzi… - European journal of …, 2021 - Springer
Introduction Fibroblast activation protein-α (FAPα) is overexpressed on cancer-associated
fibroblasts in approximately 90% of epithelial neoplasms, representing an appealing target …

Tumor buster-where will the CAR-T cell therapy 'missile'go?

C Qu, H Zhang, H Cao, L Tang, H Mo, F Liu, L Zhang… - Molecular cancer, 2022 - Springer
Chimeric antigen receptor (CAR) T cell (CAR-T cell) therapy based on gene editing
technology represents a significant breakthrough in personalized immunotherapy for human …

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

T Gargett, LM Ebert, NTH Truong… - Journal for …, 2022 - pmc.ncbi.nlm.nih.gov
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

F Zhang, Y Ma, D Li, J Wei, K Chen, E Zhang… - Journal of Hematology & …, 2024 - Springer
Metabolic reprogramming provides tumors with an energy source and biofuel to support
their survival in the malignant microenvironment. Extensive research into the intrinsic …

[HTML][HTML] Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing

AH Martínez, R Madurga, N García-Romero… - Cancer letters, 2022 - Elsevier
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent
heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper …

Tumor immune microenvironment and its related miRNAs in tumor progression

Y ** the immune microenvironment of glioblastoma: implications for immunotherapy
ECF Yeo, MP Brown, T Gargett, LM Ebert - Cells, 2021 - mdpi.com
Glioblastoma is the most common form of primary brain tumour in adults. For more than a
decade, conventional treatment has produced a relatively modest improvement in the …